FGM Performance — First Trust Germany AlphaDEX Fund
Data updated: 2026-08-21
FGM returned +2.80% year to date and +14.17% over one year to Jun 2026. Annualised returns are +19.80% over 3 years and +4.91% over 5 years. The fund beat its Germany Equity category average: $100 invested three years ago grew to $172, against $161 for the category, and to $114 over one year, against $106. Volatility over the past three years was 18.37% a year. In the 12 months to Jun 2026 the fund took in a net $29.4M, and assets reached $98.21M.
FGM Growth of $100
What $100 invested in First Trust Germany AlphaDEX Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Germany Equity category average over the same months.
| Period | FGM | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $114 | $106 |
| 3 years (Jul 2023 – Jun 2026) | $172 | $161 |
| 5 years (Jul 2021 – Jun 2026) | $127 | $148 |
| Since data start (Jul 2019 – Jun 2026) | $178 | $196 |
FGM Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +2.80% |
| 1 year | +14.17% |
| 3 years (annualised) | +19.80% |
| 5 years (annualised) | +4.91% |
FGM Annual Returns
Calendar-year total returns of First Trust Germany AlphaDEX Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +2.80% |
| 2025 | +63.51% |
| 2024 | +1.36% |
| 2023 | +12.87% |
| 2022 | −30.38% |
| 2021 | +5.73% |
| 2020 | +17.88% |
| 2019 (Jul–Dec) | +6.59% |
FGM Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +7.2% | +3.9% | −13.2% | +7.0% | +3.4% | −3.9% | — | — | — | — | — | — |
| 2025 | +9.1% | +5.3% | +4.5% | +8.2% | +9.2% | +3.8% | −1.8% | +3.4% | +2.8% | −1.0% | +1.3% | +6.0% |
| 2024 | −2.9% | +2.8% | +3.5% | −4.1% | +5.2% | −6.8% | +2.1% | +2.2% | +3.6% | −3.4% | +0.2% | −0.2% |
| 2023 | +13.2% | −2.2% | −2.1% | +3.6% | −6.9% | +7.0% | +3.5% | −3.9% | −6.3% | −6.7% | +10.9% | +4.8% |
| 2022 | −4.7% | −6.9% | −7.1% | −8.1% | +3.5% | −16.5% | +2.7% | −6.2% | −11.9% | +10.4% | +13.4% | +0.1% |
| 2021 | −0.8% | −0.2% | +5.1% | +4.2% | +5.3% | −2.4% | +0.4% | +2.2% | −6.2% | +1.4% | −4.9% | +2.2% |
| 2020 | −3.5% | −9.2% | −19.1% | +12.1% | +11.3% | +4.2% | +4.2% | +9.2% | −3.3% | −5.7% | +16.5% | +5.7% |
| 2019 | — | — | — | — | — | — | −2.7% | −4.2% | +2.8% | +4.1% | +3.5% | +3.3% |
FGM Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 18.37%
- 3-year Sharpe ratio: 0.83 (vs 4.5% risk-free rate)
- Best month: +10.94% (Nov 2023)
- Worst month: −13.17% (Mar 2026)
FGM Fund Flows
Monthly money in and out of First Trust Germany AlphaDEX Fund, from SEC Form N-PORT.
- 12-month net flow: $29.4M
- 12-month gross sales (incl. reinvestments): $57.9M
- Sales ÷ redemptions: 2.03×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $0 | $0 | $0 |
| May 2026 | $0 | $16.4M | −$16.4M |
| Apr 2026 | $0 | $0 | $0 |
| Mar 2026 | $6.2M | $6.0M | $251K |
| Feb 2026 | $30.9M | $0 | $30.9M |
| Jan 2026 | $3.3M | $3.2M | $45K |
| Dec 2025 | $6.1M | $0 | $6.1M |
| Nov 2025 | $0 | $0 | $0 |
| Oct 2025 | $0 | $0 | $0 |
| Sep 2025 | $2.9M | $2.9M | $20K |
| Aug 2025 | $2.9M | $0 | $2.9M |
| Jul 2025 | $5.7M | $0 | $5.7M |
FGM Assets Under Management
Net assets of First Trust Germany AlphaDEX Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $98.21M |
| 2026-03-31 | $108.72M |
| 2025-12-31 | $84.31M |
| 2025-09-30 | $73.47M |
| 2025-06-30 | $61.90M |
| 2025-03-31 | $16.17M |
| 2024-12-31 | $7.70M |
| 2024-09-30 | $9.97M |
| 2024-06-30 | $9.23M |
| 2024-03-31 | $12.03M |
| 2023-12-31 | $15.52M |
| 2023-09-30 | $19.89M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.